(+/-)-3-[(1R,9R,13R)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.0(2,7)]trideca-2,4,6-trien-10-yl]-1-[1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-yl]propan-1-one

ID: ALA4545050

Chembl Id: CHEMBL4545050

PubChem CID: 155553117

Max Phase: Preclinical

Molecular Formula: C32H36N2O2

Molecular Weight: 480.65

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CCC(=O)N1CCc2ccccc2C1c1ccccc1

Standard InChI:  InChI=1S/C32H36N2O2/c1-22-29-20-25-12-13-26(35)21-28(25)32(22,2)16-19-33(29)17-15-30(36)34-18-14-23-8-6-7-11-27(23)31(34)24-9-4-3-5-10-24/h3-13,21-22,29,31,35H,14-20H2,1-2H3/t22-,29+,31?,32+/m0/s1

Standard InChI Key:  ONHACLFIIHPLGZ-IQACEWDJSA-N

Alternative Forms

  1. Parent:

    ALA4545050

    ---

Associated Targets(Human)

OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Oprk1 Kappa opioid receptor (774 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 480.65Molecular Weight (Monoisotopic): 480.2777AlogP: 5.48#Rotatable Bonds: 4
Polar Surface Area: 43.78Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.47CX Basic pKa: 9.66CX LogP: 5.38CX LogD: 3.41
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.54Np Likeness Score: 0.33

References

1. Ronsisvalle S, Aricò G, Panarello F, Spadaro A, Pasquinucci L, Pappalardo MS, Parenti C, Ronsisvalle N..  (2016)  An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain.,  24  (21): [PMID:27624520] [10.1016/j.bmc.2016.08.057]

Source